The Metabolic Syndrome—What Is It and How Should It Be Managed?

Following a hypertension symposium in Portland, ME, in October 2005, a roundtable was convened to discuss the metabolic syndrome and its significance. Dr. Marvin Moser of the Yale University School of Medicine, New Haven, CT, moderated the discussion. Participating in the discussion were Dr. Bonita...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2006-01, Vol.8 (1), p.44-49
Hauptverfasser:	Moser, Marvin, Falkner, Bonita, Weber, Michael A., Keilson, Leonard Mark
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Aspirin - therapeutic use Clofibric Acid - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypolipidemic Agents - therapeutic use Metabolic Syndrome - diagnosis Metabolic Syndrome - etiology Metabolic Syndrome - therapy Obesity - complications Weight Loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Following a hypertension symposium in Portland, ME, in October 2005, a roundtable was convened to discuss the metabolic syndrome and its significance. Dr. Marvin Moser of the Yale University School of Medicine, New Haven, CT, moderated the discussion. Participating in the discussion were Dr. Bonita Falkner of the Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA; Dr. Michael A. Weber of SUNY Downstate College of Medicine, New York, NY; and Dr. Leonard Mark Keilson of the University of Vermont College of Medicine.
ISSN:	1524-6175 1751-7176
DOI:	10.1111/j.1524-6175.2006.05257.x